A Smart + Strong Site
Subscribe to:
POZ magazine
AIDS virusAralen belongs to a class of anti-HIV drugs called Immune-Based Therapies. For a description of the life-cycle of the AIDS virus, and the targets of each class of drugs, click here.

Aralen is manufactured by several companies as a generic drug.

AIDS drugs chartOur quick-reference chart allows you to compare all the currently available anti-HIV drugs, including dosing, side effects, & dietary restrictions.
news Treatment News
Search for recent news and archived stories about Aralen.
forumsHave more questions? Then post a question or comment in our Community Forums.
Help Paying for MedsHelp Paying for Meds: Patient assistance and co-pay programs for HIV and viral hepatitis drugs.
Lessons Our Lessons: Check out our informative Lessons covering various topics to help you make treatment decisions.
Collapse All

Recommended Reading List:

Books about AIDS & HIV treatmentsFor a list of great books about living with HIV and making informed treatment decisions, along with easy links to buy them from, click here.

Aralen (Chloroquine Phosphate)


What is Aralen?

  • Aralen is an anti-parasitic drug used to treat malaria. It is a generic drug manufactured widely.
  • Aralen also exerts an effect on the immune system, reducing cellular activation and overall system inflammation. Cellular activation has been linked to faster HIV disease progression and poorer CD4 cell recovery after initiating antiretroviral (ARV) therapy. Inflammation has been linked to worsening HIV disease, and to non-HIV-related conditions that include cardiovascular disease, liver disease and certain cancers.
  • Currently, Aralen is in early-state testing to determine its potency at reducing HIV-specific cellular activation and to potentially delay the need for a person to begin ARV therapy.

What is already known about Aralen?
  • Previous studies have confirmed the anti-inflammatory potential of Aralen, and a more recent study confirmed that it has a similar effect against HIV-specific CD8 cells.
  • A Phase II study is currently underway comparing 12 weeks of Aralen against a placebo in HIV-positive people who have not yet started ARV therapy. The key research questions are whether Aralen is safe to use in these individuals and whether and to what degree it is able to suppress activation of CD8 cells.
  • Like other drugs, Aralen might interact with other medications, including those used to treat HIV. It is important that your personal physician and/or the research nurse or study investigator be aware of all drugs you are taking, including those you buy without a prescription.

What is known about side effects?
  • Long-term use of Aralen can increase the risk of irreversible damage to the retina of the eye. People who are taking Aralen are recommended to have regular eye exams and to report any changes in eyesight to their doctors right away.
  • Aralen can cause stomach upset, including nausea, diarrhea and cramping.
  • Aralen can also cause skin and hair changes, including rash, sun sensitivity, hair loss and bleaching of the hair.
  • Aralen can cause muscle weakness and nerve problems.
  • Aralen can cause or worsen seizures.

Who should not take Aralen?
  •  People allergic to drugs that are similar to Aralen—a class of drugs called “quinalones”—should not take Aralen. Allergic reactions to Aralen can be life-threatening.
  • Pregnant women should not use Aralen, unless they have acute malaria, as the drug can be harmful to a developing fetus.
  • Aralen can pass into the breast milk and may have a harmful effect on an infant. Women taking Aralen are encouraged not to breast feed while taking Aralen. Also, to prevent transmission of the virus to uninfected babies, it is recommended that HIV-positive mothers not breast feed.

Where can I learn more about clinical trials of Aralen?
  • If you would like to find out if you are eligible for any clinical trials that include Aralen, visit, a site run by the U.S. National Institutes of Health. The site has information about all HIV-related clinical studies in the United States. For more info, you can call their toll-free number at 1-800-HIV-0440 (1-800-448-0440) or email

Last Revised: February 10, 2011

This content is written by the POZ and AIDSmeds editorial team. For more information, please visit our "About Us" page.

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.